Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine discontinuation in subclinical hypothyroidism
NCT04288115Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levothyroxine sodium in hypothyroidism, sponsored by VA Office of Research & Development. Started Mar 2021; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT04288115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288115.